CLDN1 and malignant colon neoplasm: Smad4 is a central intracellular signal transduction component of the TGF-β family that was described to mediate invasion suppressive effects in colon cancer via the modulation of β-catenin/TCF-LEF activity, resulting in the repression of CLDN1 transcription [88].